학술논문
Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease
Document Type
Article
Author
Gong, J.; He, G.; Wang, C.; Panjwani, N.; Mastromatteo, S.; Lin, F.; Keenan, K.; Halevy, A.; Esmaeili, M.; Rommens, J.M.; Strug, L.J.; Sun, L.; Bartlett, C.; Avolio, J.; Shaw, M.; Moraes, T.J.; Gonska, T.; Ratjen, F.; Côté-Maurais, G.; Adam, D.; Bégin, S.; Brochiero, E.; Berthiaume, Y.; Bjornson, C.; Chilvers, M.; Reisman, J.; Price, A.; Parkins, M.; van Wylick, R.; Bilodeau, L.; Mateos-Corral, D.; Hughes, D.; Smith, M.J.; Morrison, N.; Brusky, J.; Tullis, E.; Stephenson, A.L.; Quon, B.S.; Wilcox, P.; Leung, W.M.; Solomon, M.
Source
In: npj Genomic Medicine . (npj Genomic Medicine, December 2022, 7(1))
Subject
Language
English
ISSN
20567944